Predictors of the need for prophylactic percutaneous endoscopic gastrostomy in head and neck cancer patients treated with concurrent chemoradiotherapy.

Satoshi KanoNayuta TsushimaTakayoshi SuzukiSeijiro HamadaTaizo YokokawaHiroshi IdogawaKoichi YasudaHideki MinatogawaYasuhiro DekuraHidefumi AoyamaAkihiro Homma

Published in: International journal of clinical oncology (2021)

Prophylactic PEG is effective for patients treated with definitive CCRT and is especially required for patients with PS2 or oropharyngeal cancer.

Keyphrases

locally advanced
ultrasound guided
rectal cancer
papillary thyroid

squamous cell carcinoma
radiation therapy
squamous cell

drug delivery
minimally invasive
lymph node metastasis

radiofrequency ablation
childhood cancer
young adults